CRISPR Therapeutics AG Stock Predictions

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Sell

CRSP
CRISPR Therapeutics AG

Last Price:

$37.55

Seasonality Move:

22.33%

7 Day Trial

ALL ACCESS PASS

$ 7

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here

CRISPR Therapeutics AG Stock Forecast

Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 30.3% based on the past 8 years of stock performance.
CRISPR Therapeutics AG has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
Is CRISPR Therapeutics AG Stock Undervalued?

The current CRISPR Therapeutics AG [CRSP] share price is $35.62. The Score for CRSP is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
CRSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will CRISPR Therapeutics AG Stock Go Up Next Year?

Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 30.3% based on the past 8 years of stock performance.

CRISPR Therapeutics AG Stock Rating

Sell

CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG overpriced?

CRISPR Therapeutics AG has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%

CRISPR Therapeutics AG Stock Price History

Is CRSP stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

Switzerland

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

crisprtx.com

52-Week Data

52-Week High:

67.88

52-Week Low:

30.04

Prediction Charts

Market Cap:

3.1B

Price in USD:

35.62

Volume:

1.7M

Beta:

2.03

Technical Analysis

SMA50:

38.67

SMA100:

40.60

SMA200:

44.81

52-Wk Change:

-33.48%

Stock Predictions

Is CRISPR Therapeutics AG stock public?

Yes, CRISPR Therapeutics AG is a publicly traded company.
What is the CRISPR Therapeutics AG stock quote today?

The CRISPR Therapeutics AG stock price is 35.62 USD today.
How to buy CRISPR Therapeutics AG stock online?

You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-22	38.49	39.23	39.85	38.34
Apr-23	40.11	38.54	40.73	38.54
Apr-24	38.73	39.11	39.35	38.25
Apr-25	38.73	38.27	39.05	37.93
Apr-28	38.37	37.88	39.40	37.46
Apr-29	37.88	37.40	38.29	37.24
Apr-30	36.78	38.67	38.88	36.06
May-1	38.67	37.73	38.70	37.28
May-2	38.18	38.25	39.38	38.00
May-5	37.88	37.62	38.49	37.33
May-6	36.92	33.16	36.97	33.03
May-7	34.51	34.25	34.64	33.50
May-8	34.88	36.14	36.86	34.12
May-9	36.39	35.62	37.34	35.55

CRISPR Therapeutics AG Earnings

CRISPR Therapeutics AG Earnings Report: Per Share CRISPR Therapeutics AG Earnings Q1 Q2 Q3 and Q4 last year and next year.

CRISPR Therapeutics AG Forecast Revenue Growth

CRISPR Therapeutics AG Stock Analysis: Historical quarterly revenues per share for CRISPR Therapeutics AG and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.09 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.24 per share, and an increase next year of $1.00 per share.

* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.